Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread pain, stiffness, or aching in the large muscle groups, especially around the shoulders, hips, lower back, neck, and ...

Polymyalgia rheumatica (PMR) is an inflammatory disease, mostly seen in older adults, that causes pain and stiffness in certain areas of the body — often in the neck, shoulders, or hip area. These ...

Findings showed secukinumab demonstrated statistically significant and clinically meaningful sustained remission at week 52 vs placebo. Topline data were announced from a phase 3 trial evaluating ...

Polymyalgia rheumatica (PMR) is a common inflammatory disorder that causes pain, usually in your shoulders and upper body. Inflammation is your body’s natural response when it’s trying to protect you ...

Polymyalgia rheumatica (PMR) is an inflammatory disorder that causes severe muscle pain, muscle stiffness, muscle spasms and cramping on both sides of the body, particularly in the shoulders, neck, ...

In this article, Lally and colleagues present the results of an open-label trial of the anti-interleukin (IL)-6 receptor agent tocilizumab in 10 patients with isolated polymyalgia rheumatica (PMR).

All About Polymyalgia Rheumatica and Temporal Arteritis: From Symptoms to Treatments: By Shreoshree Chakrabarty Polymyalgia rheumatica (PMR) and temporal arteritis, also known as giant cell arteritis ...

Background: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of ...

Polymyalgia rheumatica (PMR) is an inflammatory disease that causes pain and stiffness in major muscle groups of your body, often including your neck, shoulders, and hip area. It’s the most common ...

Giant cell arteritis (GCA) is a large-vessel and medium-vessel vasculitis that predominantly affects the thoracic aorta and its branches. The credit of recognizing GCA as a disease with specific ...

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...